Hudson Bay Capital Management’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-100,000
| Closed | -$145K | – | 870 |
|
|
2024
Q1 | $145K | Hold |
100,000
| – | – | ﹤0.01% | 508 |
|
|
2023
Q4 | $9.99K | Hold |
100,000
| – | – | ﹤0.01% | 540 |
|
|
2023
Q3 | $15K | Hold |
100,000
| – | – | ﹤0.01% | 603 |
|
|
2023
Q2 | $9K | Hold |
100,000
| – | – | ﹤0.01% | 687 |
|
|
2023
Q1 | $6K | Hold |
100,000
| – | – | ﹤0.01% | 758 |
|
|
2022
Q4 | $4.56K | Hold |
100,000
| – | – | ﹤0.01% | 863 |
|
|
2022
Q3 | $7K | Hold |
100,000
| – | – | ﹤0.01% | 1096 |
|
|
2022
Q2 | $15K | Hold |
100,000
| – | – | ﹤0.01% | 1151 |
|
|
2022
Q1 | $30K | Hold |
100,000
| – | – | ﹤0.01% | 1043 |
|
|
2021
Q4 | $51K | Hold |
100,000
| – | – | ﹤0.01% | 979 |
|
|
2021
Q3 | $55K | Hold |
100,000
| – | – | ﹤0.01% | 893 |
|
|
2021
Q2 | $101K | Buy |
+100,000
| New | +$101K | ﹤0.01% | 851 |
|